Using Newly FDA Approved Gilteritinib For Patients With AML

Using Newly FDA Approved Gilteritinib For Patients With AML

User Photo
obr

1 year
22 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
James McClosky, MD Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center, discusses Using Newly FDA Approved Gilteritinib For Patients With AML. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Up Next Autoplay
User Photo